Vitrectomy
41
0
0
28
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
7.3%
3 terminated out of 41 trials
90.3%
+3.8% vs benchmark
10%
4 trials in Phase 3/4
25%
7 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (41)
Clinical Study to Confirm the Safety and Performance of the Virtuoso Phaco-vitrectomy Device
Influence of Tamponade on Retinal Shift in Eyes Undergoing Vitrectomy for Rhegmatogenous Retinal Detachment: A Comparison of Gas Versus Silicone Oil in a Pakistani Population
Patient-preferred Aromatherapy Versus Placebo For Reducing Preoperative Anxiety In Patients Undergoing Eye Surgery
Analgesic Effect and Safety of Oliceridine and Oxycodone in Vitrectomy
Postoperative Same Day Closure of Giant Macular Hole With Silicone Oil
A Study to Evaluate the Safety and Performance of the Vista Probe for Vitrectomy Surgery
Objective Measurements of the Opacification of the Lens After Vitrectomy
Postoperative Evolution After Small Gauge Vitrectomy Without Eye Occlusion
Endoscopic Assisted Anterior Hyaloid Peeling in Boston Type 1 Keratoprosthesis (KPro-HP-Endo)
Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.
Observation of the Efficacy of Different Vitrectomy Systems to Treat Proliferative Diabetic Retinopathy
Performance Comparison of the 25 Gauge 20,000cpm HYPERVIT Dual Blade vs. 10,000cpm ULTRAVIT Vitrectomy Cutter
IRIS Alfa Clinical Trial A Monocentric, Academic Clinical Trial Safety Study of a Prototype of a New Vitrectomy Device.
Beveled-Tip Versus(vs) Standard-Tip Vitrectomy Probe
Pars Plana Vitrectomy With 25-gauge 20000 Cpm, Bevel-tip Cutter
The Safety Outcomes of 27 Gauge Vitrectomy for Posterior Segment Disease in High Myopia
Oral Sedation in Vitreoretinal Surgery
IRIS Hook Assisted Phacoemulsification in Vitrectomized Eyes
Influence of HFNO on Spontaneous Ventilation in Patients of Different ASA Risk During Analgo-sedation for Vitrectomy
Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema